Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.
The Lancet. Oncology.
Times cited: 15
Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.
Clinical genitourinary cancer.
Times cited: 2
- Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer research. 2005 Academic Article GET IT